B10.0 Other human herpesvirus encephalitis

Name of the Condition

• Other human herpesvirus encephalitis

Summary

Other human herpesvirus encephalitis is a rare but serious neurological condition caused by infection of the brain with herpesviruses other than herpes simplex virus (HSV). It typically presents with acute or subacute inflammation of the brain parenchyma, leading to symptoms such as altered mental status, fever, and focal neurological deficits. The condition may progress rapidly and requires prompt medical attention to mitigate potential complications.

Causes

Other human herpesvirus encephalitis is caused by specific members of the Herpesviridae family, including cytomegalovirus (CMV), human herpesvirus 6 (HHV-6), human herpesvirus 7 (HHV-7), and human herpesvirus 8 (HHV-8). These viruses can invade the central nervous system, either through primary infection or reactivation of latent virus, leading to inflammation and tissue damage. Transmission routes vary by virus but may include direct contact with infected bodily fluids or respiratory droplets.

Risk Factors

• Immunocompromised states, such as HIV/AIDS, organ transplantation, or chemotherapy.
• Advanced age, particularly for HHV-8-associated conditions.
• Congenital or perinatal exposure to cytomegalovirus.
• Close contact with individuals shedding the virus.

Symptoms

• Altered mental status, confusion, or disorientation.
• Fever, headache, and neck stiffness.
• Focal neurological deficits, such as weakness, seizures, or speech difficulties.
• Nausea, vomiting, or photophobia.
• Progression to coma in severe cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, neuroimaging (e.g., MRI or CT scans), and laboratory testing. Cerebrospinal fluid (CSF) analysis may show elevated white blood cells, protein, or viral DNA via PCR. Neuroimaging helps identify characteristic patterns of brain inflammation. Serological testing or viral culture may also be used to confirm the specific herpesvirus involved.

Treatment Options

Treatment typically includes antiviral medications (e.g., ganciclovir, foscarnet) targeted at the identified herpesvirus. Supportive care, such as managing seizures or intracranial pressure, may be necessary. Corticosteroids are sometimes used to reduce inflammation, though their role depends on the specific virus and clinical context. Hospitalization is often required for close monitoring and supportive interventions.

Prognosis and Follow-Up

Prognosis varies based on the virus, patient age, and timeliness of treatment. Early intervention improves outcomes, but severe cases may result in long-term neurological deficits or mortality. Follow-up care includes monitoring for recurrence, managing complications, and rehabilitation for residual symptoms. Regular neurological assessments are recommended to track recovery.

Complications

• Permanent neurological damage, such as cognitive impairment or motor deficits.
• Seizures or epilepsy.
• Increased intracranial pressure leading to brain herniation.
• Death in severe or untreated cases.
• Recurrence of infection in immunocompromised individuals.

Lifestyle & Prevention

• Maintain good hygiene to reduce exposure to viral infections.
• Avoid close contact with individuals showing signs of herpesvirus infections.
• Ensure vaccination against preventable herpesviruses (e.g., varicella-zoster).
• Manage underlying immunocompromised conditions to reduce reactivation risk.
• Seek prompt medical care for symptoms of encephalitis.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden onset of fever, severe headache, confusion, or neurological symptoms (e.g., weakness, seizures). Early diagnosis and treatment are critical to improve outcomes. Individuals with weakened immune systems should be particularly vigilant for signs of infection.

Tips for Medical Coders

When coding for other human herpesvirus encephalitis (ICD-10-CM code B10.0), ensure documentation supports the specific herpesvirus involved and confirms encephalitis as the primary condition. Include details such as clinical presentation, diagnostic findings (e.g., CSF analysis, imaging), and treatment provided. Verify that the code aligns with the patient’s diagnosis and that no other codes (e.g., for HSV encephalitis) are more appropriate. Accurate documentation of the causative virus and neurological involvement is essential for correct coding.